GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Zydus Lifesciences Ltd

Zydus Lifesciences forms JV in Sri Lanka with Sunshine Healthcare

JV / MOU ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 26 Jun 2026, 07:55 AM IST  ·  BSE ID: 9a5bf3bb-c78b-485c-906b-c96763ae5ccc
View Original BSE Filing (PDF)
💡
In Simple Terms
Zydus Lifesciences is creating a new joint company in Sri Lanka by partnering with Sunshine Healthcare Lanka Limited.
🤖 AI Summary
  • Zydus Lifesciences invests in 50% equity of Zydus Sunshine Lifesciences in Sri Lanka.
  • Joint venture formed with Sunshine Healthcare Lanka Limited via SSSHA.
  • Zydus Sunshine Lifesciences (Private) Limited is the target entity.
  • Investment made via Share Subscription and Shareholders' Agreement.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Zydus Lifesciences Subscription Share %
50%
🏢 How This Affects the Company
📈
Business Impact
This move expands Zydus Lifesciences' geographical footprint into the Sri Lankan pharmaceutical market through a joint venture structure. It allows for shared operational responsibilities and market access.
💰
Financial Impact
The filing details an investment in equity shares, indicating capital outflow for Zydus Lifesciences. Specific financial commitment figures are detailed in the annexures, impacting the company's investment portfolio.
⚙️
Operational Impact
The formation of Zydus Sunshine Lifesciences establishes a new operational entity in Sri Lanka, requiring integration with existing business strategies and compliance with local regulations.
⚠️
Risk Impact
Entering a new joint venture introduces operational and market-specific risks associated with the Sri Lankan pharmaceutical landscape. Risk is mitigated through partnership with Sunshine Healthcare Lanka.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this joint venture formation.
👤
Who Is Affected
All shareholders of Zydus Lifesciences are affected by strategic expansion initiatives that may influence future growth and profitability.
🔍
Management Signal
This demonstrates management's intent to pursue strategic partnerships for international market expansion and diversification.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Details of Zydus Sunshine Lifesciences operations.
Financial performance of the joint venture.
Future expansion plans in Sri Lanka.
MEDIUM RISK Joint venture in a new international market carries inherent operational and regulatory risks.
💡 Investor Takeaway
Zydus Lifesciences has entered a Share Subscription and Shareholders' Agreement to form a 50% joint venture, Zydus Sunshine Lifesciences, in Sri Lanka with Sunshine Healthcare Lanka Limited.
❓ Frequently Asked Questions
What is the name of the target entity for Zydus Lifesciences' joint venture?
The target entity is Zydus Sunshine Lifesciences (Private) Limited.
What is Zydus Lifesciences' stake in the new Sri Lankan joint venture?
Zydus Lifesciences will subscribe to 50% of the total paid-up equity share capital of Zydus Sunshine Lifesciences.
Who is the partner in the Zydus Sunshine Lifesciences joint venture?
The partner is Sunshine Healthcare Lanka Limited.
What agreement governs the formation of the joint venture?
The joint venture is governed by a Share Subscription and Shareholders' Agreement (SSSHA).

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.